REG - Creightons PLC - Issue of Equity and TVR

CreightonsAnnouncement

01/04/2019 16:55

RNS Number : 7429U
Creightons PLC
01 April 2019
 


 
FOR IMMEDIATE RELEASE                                                                            1 April 2019
 
CREIGHTONS PLC ("Creightons" or "the Company")
Issue of Equity
Total Voting Rights
The Company today announces that it has issued from its block listing authority of 20 March 2019 in respect of employee share options 124,000 new Ordinary Shares of 1p each at a price of 4.50 pence per share; these shares rank pari passu with the existing Ordinary Shares in issue. 
Following this issue, the Company has the ability to issue a further 2,551,100 Ordinary Shares under its block listing facility. 
As a result of this issue, the total number of ordinary shares in issue now stands at 62,546,143 and the total number of voting rights in the Company is 62,546,143.
The above figure of 62,546,143 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
 
This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014 on market abuse.  Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
 
Enquiries - Analysts and Investors
Nicholas O'Shea, Director, Creightons Plc                                                         01733 281000
Roland Cornish / Felicity Geidt, Beaumont Cornish Limited                           0207 628 3396
Authorised for release
 
Nicholas O'Shea, Director, Creightons plc
1 April 2019




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEUGUUACUPBGAG